Sunday, October 18, 2026

USD/EUR Bullish By 2% In The Last 10 Sessions

ViaNews Editorial Team

October 11, 2024

USD/EUR Bullish By 2% In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.13% for the last 10 sessions. At 08:09 EST on Friday, 11 October, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 2.489% up from its 52-week low and 4.052% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was 0.28%, 0.04%, and 0.28%, respectively.

USD/EUR's highest amplitude of average volatility was 0.30% (last week), 0.29% (last month), and 0.28% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • According to FXStreet on Wednesday, 9 October, "This, along with the fact that oscillators on the daily chart have been gaining positive traction, suggests that the path of least resistance for the USD/JPY pair is to the upside. ", "Apart from this, subdued US Dollar (USD) demand fails to assist the USD/JPY pair to capitalize on the overnight bounce from the 147.35-147.30 region and contributes to the range-bound price action during the Asian session on Wednesday. "
  • Usd/jpy price forecast: surges above 149.00 sponsored by elevates US yields. According to FXStreet on Wednesday, 9 October, "If USD/JPY extends its gains above the August 15 high of 149.39, the 150.00 figure will be exposed. ", "The USD/JPY rallied and pushed above 149.00 for the first time since mid-August, sponsored by the jump in US Treasury yields due to their close positive correlation with the pair. "
  • According to FXStreet on Thursday, 10 October, "This, in turn, should help limit the downside for the USD/JPY pair near the 148.00 round figure. ", "Moreover, oscillators on the daily chart have been gaining positive traction and are away from being in the overbought territory, suggesting that the path of least resistance for the USD/JPY pair is to the upside. "
  • Usd/jpy can remain sensitive to US rates – DBS. According to FXStreet on Thursday, 10 October, "With speculative positioning still not deeply short, intervention does not appear to be an imminent risk, and USD/JPY could remain sensitive to US rates for now."
  • According to FXStreet on Friday, 11 October, "The Japanese Yen (JPY) struggles to attract any meaningful buyers during the Asian session on Friday, with the USD/JPY pair holding just below its highest level since early August touched the previous day. ", "Moreover, oscillators on the daily chart have been gaining positive traction and are far from being in the overbought territory, suggesting that the path of least resistance for the USD/JPY pair is to the upside. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,396 source documents archived
Query this data → isubstrate.com